Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age

Sponsor
University of Georgia (Other)
Overall Status
Completed
CT.gov ID
NCT01743196
Collaborator
(none)
32
1
31
1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if there is a difference in the short term response in serum folate after a single dose of folic acid in normal weight and obese women of childbearing age.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Current recommendations established in 1998, specify that all women capable of becoming pregnant consume 400 micrograms of folate daily from supplements, fortified foods, or both, in addition to consuming food folate from a varied diet. Despite this recommendation, obese women have a lower folate status than women of normal weight which suggests that obesity may have a negative impact on folate metabolism. Therefore, the objective of this study is to determine if there are differences in the metabolic response to a single dose of folate between normal weight and obese women of child bearing age. The two groups of women will be given the currently recommended amount of folic acid, 400 micrograms, and blood samples will be taken before the vitamin is given and at various points afterwards to determine serum folate response to the folate dose. Results of this research should help determine if folate requirements are higher for obese than for non-obese women. The long-term goal of this and follow-up studies is to generate data that will contribute to the evidence base used by scientific advisory panels to determine whether dietary folate intake recommendations should be based on body weight.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    32 participants
    Official Title:
    Pilot Study of Folate Pharmacokinetics in Normal Weight and Obese Women of Child-bearing Age
    Study Start Date :
    May 1, 2012
    Actual Primary Completion Date :
    Aug 1, 2012
    Actual Study Completion Date :
    Dec 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Normal weight

    Women with BMI 18.5 to 24.9 kg/m2

    Obese

    Women with BMI > 30 kg/m2

    Outcome Measures

    Primary Outcome Measures

    1. Area under the serum concentration versus time curve (AUC) for folic acid [0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0 10.0 hours post-dose]

      Change from baseline in serum folate response at the indicated time points following oral intake of a 400 ug dose of folic acid will be calculated by subtracting the baseline concentrations from the folate value at each subsequent time point. Individual response-time curves will be generated and area-under-the-curve (AUC) calculated using the trapezoidal rule.

    Secondary Outcome Measures

    1. Peak Serum Concentration (Cmax) of Folate [up to 10 hours]

      Maximum folate concentration in response to an oral dose of 400 ug folic acid. Values are derived from the individual response curves.

    2. Time to peak concentration (tmax) of folate [up to 10 hours]

      Time to peak serum concentration of folate following the oral administration of a 400 ug dose of folic acid. Values are derived from the individual response curves.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Female 18-35 yr

    • Caucasian

    • Body mass index 18.5 - 24.9 or > 30 kg/m2

    Exclusion Criteria:
    • Currently pregnant, pregnancy within the past 12 months

    • Greater than 2 previous pregnancies

    • Use of prescription drugs other than oral contraceptives

    • Chronic disease (diabetes, hypertension, epilepsy, cancer, kidney disease, cardiovascular disease)

    • Acute illness (e.g. pneumonia, urinary tract infection, mononucleosis)

    • Use of antibiotics in past 30 days

    • Current smoker

    • Use of dietary supplements including multivitamins in the past 30 days

    • Significant weight change in past 12 months

    • Typical alcohol consumption of 2 or more drinks per day

    • Consumption of any alcohol in the week preceding testing

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Georgia Athens Georgia United States 30602

    Sponsors and Collaborators

    • University of Georgia

    Investigators

    • Principal Investigator: Lynn B Bailey, PhD, University of Georgia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lynn B. Bailey, PhD, Department Head and Professor, University of Georgia
    ClinicalTrials.gov Identifier:
    NCT01743196
    Other Study ID Numbers:
    • UGAFOLATEPILOT
    First Posted:
    Dec 6, 2012
    Last Update Posted:
    Oct 21, 2015
    Last Verified:
    Oct 1, 2015
    Keywords provided by Lynn B. Bailey, PhD, Department Head and Professor, University of Georgia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 21, 2015